The board of directors at WindMIL Therapeutics has a history of experience with cancer and prostate cancer specifically. The current chief science officer previously worked at The Prostate Cancer Foundation, giving them significant experience in the topic. Additionally, many members of the board have received education in related fields such as biology and medicine. This gives the board a wealth of knowledge to draw upon when making decisions for the company.
Anna French
Director
Brian Dovey
Director
Daniel O’Donnell
Director
Drew Pardoll
Scientific Advisor
Howard Soule
Director
Ivan Borrello
Scientific Advisor
Jeffrey Weber
Scientific Advisor
Kenneth Anderson
Scientific Advisor
Marcela V. Maus
Scientific Advisor
Mark McDade
Director
Martin J. Edelman
Scientific Advisor
View all